Lion Point Capital, LP

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
21
Total Value
15675769
Accession Number
0001013594-25-000673
Form Type
13F-HR
Manager Name
Lion-Point-Capital-Lp
Data Enrichment
100% identified
21 identified0 unidentified

Holdings

21 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
INSMED Inc
Shares:30.5K
Value:$2.3M
ARDELYX, INC.
Shares:335.4K
Value:$1.6M
Mineralys Therapeutics, Inc.
Shares:79.0K
Value:$1.3M
FENNEC PHARMACEUTICALS INC.
Shares:195.7K
Value:$1.2M
Kiniksa Pharmaceuticals International, plc
Shares:45.9K
Value:$1.0M
BridgeBio Pharma, Inc.
Shares:26.0K
Value:$898.8K
Benitec Biopharma Inc.
Shares:62.0K
Value:$806.6K
GERON CORP
Shares:500.0K
Value:$795.0K
AVADEL PHARMACEUTICALS PLC
Shares:98.7K
Value:$772.8K
Arcutis Biotherapeutics, Inc.
Shares:46.3K
Value:$724.1K
Syndax Pharmaceuticals Inc
Shares:55.0K
Value:$675.7K
Jasper Therapeutics, Inc.
Shares:146.5K
Value:$630.0K
Biohaven Ltd.
Shares:22.7K
Value:$545.7K
Disc Medicine, Inc.
Shares:10.6K
Value:$526.2K
Milestone Pharmaceuticals Inc.
Shares:548.8K
Value:$439.1K
REGENXBIO Inc.
Shares:57.8K
Value:$412.9K
bluebird bio, Inc.
Shares:78.9K
Value:$385.1K
Seres Therapeutics, Inc.
Shares:340.8K
Value:$238.5K
Mersana Therapeutics, Inc.
Shares:644.0K
Value:$221.7K
Humacyte, Inc.
Shares:83.5K
Value:$142.4K